T2DM is characterized by insulin resistance, hyperglycemia, and dyslipidemia (Jaishree and Narsimha, 2020), with oxidative stress being a key contributor to its complications, as reflected by alterations in MDA levels and SOD activity (Xie et al., 2021). The gene discussed is SOD1; the disease is Insulin resistance.